3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Other
1
Head & Neck
1
Conditions
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Uterine Cervical Neoplasms
2
Stomatitis
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Hematologic Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Squamous Intraepithelial Lesions
1
Soft Tissue Neoplasms
1
Radiodermatitis
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Pain
1
Ovarian Neoplasms
1
Neoplasms
1
Mucositis
1
HIV Infections
1
Endometrial Neoplasms
1
Eczema
1
Dermatitis
1
Cicatrix
1
Cancer Pain
1
Interventions
Cyclophosphamide
32
Tacrolimus
29
fludarabine
27
Mycophenolic Acid
23
fludarabine phosphate
22
Busulfan
19
Whole-Body Irradiation
18
Melphalan
16
Methotrexate
15
Antilymphocyte Serum
14
Rituximab
12
Bortezomib
11
Stem Cell Transplantation
10
Cyclosporine
10
thymoglobulin
9
Sirolimus
9
Granulocyte Colony-Stimulating Factor
9
Peripheral Blood Stem Cell Transplantation
8
Thiotepa
7
Interviews as Topic
7
Filgrastim
7
Dexamethasone
7
Clofarabine
7
Blood Specimen Collection
6
Alemtuzumab
6
merphos
5
Voriconazole
5
Standard of Care
5
Nivolumab
5
Lenalidomide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Hematologic Neoplasms
×
Laser Therapy
×
Clear all
NCT07069153
2025-11-17
LOMUC
University of Pavia
Phase NA
Completed
40 enrolled
NCT02696408
2020-01-29
STOP MUCITES
Institut de Cancérologie de la Loire
Phase 3
Completed
234 enrolled